These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23561488)

  • 1. Discovering human immunodeficiency virus mutational pathways using temporal Bayesian networks.
    Hernandez-Leal P; Rios-Flores A; Avila-Rios S; Reyes-Terán G; Gonzalez JA; Fiedler-Cameras L; Orihuela-Espina F; Morales EF; Sucar LE
    Artif Intell Med; 2013 Mar; 57(3):185-95. PubMed ID: 23561488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting human immunodeficiency virus inhibitors using multi-dimensional Bayesian network classifiers.
    Borchani H; Bielza C; Toro C; Larrañaga P
    Artif Intell Med; 2013 Mar; 57(3):219-29. PubMed ID: 23375464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel drug resistance mutations in HIV: recognition and clinical relevance.
    Perno CF; Svicher V; Ceccherini-Silberstein F
    AIDS Rev; 2006; 8(4):179-90. PubMed ID: 17219733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of treatment with first-line lopinavir boosted with ritonavir can be explained by novel resistance pathways with protease mutation 76V.
    Nijhuis M; Wensing AM; Bierman WF; de Jong D; Kagan R; Fun A; Jaspers CA; Schurink KA; van Agtmael MA; Boucher CA
    J Infect Dis; 2009 Sep; 200(5):698-709. PubMed ID: 19627247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of HIV resistance during treatment interruption in experienced patients and after restarting a new therapy.
    Balduin M; Sierra S; Däumer MP; Rockstroh JK; Oette M; Fätkenheuer G; Kupfer B; Beerenwinkel N; Hoffmann D; Selbig J; Pfister HJ; Kaiser R
    J Clin Virol; 2005 Dec; 34(4):277-87. PubMed ID: 16191482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian analysis of complex interacting mutations in HIV drug resistance and cross-resistance.
    Kozyryev I; Zhang J
    Adv Exp Med Biol; 2015; 827():367-83. PubMed ID: 25387976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of HIV-1 pol sequences using Bayesian Networks: implications for drug resistance.
    Deforche K; Silander T; Camacho R; Grossman Z; Soares MA; Van Laethem K; Kantor R; Moreau Y; Vandamme AM;
    Bioinformatics; 2006 Dec; 22(24):2975-9. PubMed ID: 17021157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral drug resistance mutations in antiretroviral-naive prisoners.
    Stone DR; Corcoran C; Wurcel A; McGovern B; Quirk J; Brewer A; Sutton L; D'Aquila RT
    Clin Infect Dis; 2002 Oct; 35(7):883-6. PubMed ID: 12228827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of human immunodeficiency virus drug resistance: an update.
    Menéndez-Arias L
    Antiviral Res; 2010 Jan; 85(1):210-31. PubMed ID: 19616029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.
    García-Lerma JG; MacInnes H; Bennett D; Weinstock H; Heneine W
    J Virol; 2004 Jul; 78(14):7545-52. PubMed ID: 15220429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E17A mutation in HIV-1 Vpr confers resistance to didanosine in association with thymidine analog mutations.
    Fourati S; Malet I; Guenzel CA; Soulie C; Maidou-Peindara P; Morand-Joubert L; Wirden M; Sayon S; Peytavin G; Simon A; Katlama C; Benichou S; Calvez V; Marcelin AG
    Antiviral Res; 2012 Jan; 93(1):167-74. PubMed ID: 22138483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of antiretroviral resistance genotypes with response to therapy--comparison of three models.
    Quigg M; Frost SD; McDonagh S; Burns SM; Clutterbuck D; McMillan A; Leen CS; Brown AJ
    Antivir Ther; 2002 Sep; 7(3):151-7. PubMed ID: 12487381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired CD4+ cell recovery during antiretroviral therapy in patients with HIV resistance mutations.
    Sühs KW; Stoll M; Diem R; Schmidt RE; Heiken H
    Arch Virol; 2012 Mar; 157(3):433-40. PubMed ID: 22179846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance and replication capacity assays: clinical utility and interpretation.
    Haubrich RH
    Top HIV Med; 2004; 12(2):52-6. PubMed ID: 15184711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy.
    Recsky MA; Brumme ZL; Chan KJ; Wynhoven B; Yip B; Dong WW; Heath KV; Montaner JS; Levy AR; Hogg RS; Harrigan PR
    J Infect Dis; 2004 Jul; 190(2):285-92. PubMed ID: 15216463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of HIV-1 pol sequences from Panama: identification of phylogenetic clusters within subtype B and detection of antiretroviral drug resistance mutations.
    Ahumada-Ruiz S; Flores-Figueroa D; Toala-González I; Thomson MM
    Infect Genet Evol; 2009 Sep; 9(5):933-40. PubMed ID: 19559103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human immunodeficiency virus resistance to antiretroviral drugs].
    Karmochkine M; Descamps D
    Ann Med Interne (Paris); 1999 Dec; 150(8):615-22. PubMed ID: 10686643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic barrier to antiretroviral drug-resistance. Focus on raltegravir, the first integrase inhibitor].
    Delaugerre C
    Med Mal Infect; 2010 Sep; 40 Suppl 1():S1-10. PubMed ID: 20800182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy.
    Nicastri E; Sarmati L; d'Ettorre G; Palmisano L; Parisi SG; Uccella I; Rianda A; Concia E; Vullo V; Vella S; Andreoni M
    J Med Virol; 2003 Jan; 69(1):1-6. PubMed ID: 12436471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.